Exploring reasons for higher breast cancer risk among Caribbean women

by Sylvester Comprehensive Cancer CenterSylvester researcher Sophia George, Ph.D., who was raised in the Caribbean country of Dominica. Credit: Sylvester Comprehensive Cancer CenterA new study from re

Updated on: November 11,2024

Exploring reasons for higher breast cancer risk among Caribbean women

by Sylvester Comprehensive Cancer CenterSylvester researcher Sophia George, Ph.D., who was raised in the Caribbean country of Dominica. Credit: Sylvester Comprehensive Cancer CenterA new study from re

Updated on:November 11,2024

Study maps alterations that make melanoma more severe, could lead to better therapies and diagnosis

by André Julião,FAPESPStudy design, resources and methodology. A major aim (steps 1–2) is the discovery and validation of genome-wide methylation alterations associated with the UV mutational si

Updated on: February 20,2024

Study maps alterations that make melanoma more severe, could lead to better therapies and diagnosis

by André Julião,FAPESPStudy design, resources and methodology. A major aim (steps 1–2) is the discovery and validation of genome-wide methylation alterations associated with the UV mutational si

Updated on:February 20,2024

Boosting immunotherapy in non-responsive cancer cells

by Surabhi Chandra,Indian Institute of ScienceAvik Chattopadhyay working in the lab. Credit: Nikita RamtekeCancer immunotherapy primes a patient's immune system to better find and destroy ca

Updated on: January 26,2024

Boosting immunotherapy in non-responsive cancer cells

by Surabhi Chandra,Indian Institute of ScienceAvik Chattopadhyay working in the lab. Credit: Nikita RamtekeCancer immunotherapy primes a patient's immune system to better find and destroy ca

Updated on:January 26,2024

American cancer survivors face substantial financial hardship and financial sacrifices

byAmerican Association for Cancer ResearchAmerican cancer survivors, particularly those 64 years or younger, faced substantial medical financial hardship and sacrifices in spending, savings, or

Updated on: December 20,2023

American cancer survivors face substantial financial hardship and financial sacrifices

byAmerican Association for Cancer ResearchAmerican cancer survivors, particularly those 64 years or younger, faced substantial medical financial hardship and sacrifices in spending, savings, or

Updated on:December 20,2023

A blood sample 24 hours after the start of chemotherapy can predict survival

byUniversity of BergenMass cytometry analysis of early response evaluation by single-cell signaling to profile.aPeripheral blood samples were collected from 32 AML patients treated w

Updated on: December 25,2023

A blood sample 24 hours after the start of chemotherapy can predict survival

byUniversity of BergenMass cytometry analysis of early response evaluation by single-cell signaling to profile.aPeripheral blood samples were collected from 32 AML patients treated w

Updated on:December 25,2023

Gene loss enhances metastasis and cancer progression

by Melissa Rohman,Northwestern UniversityAn in vivo genome-wide CRISPR-Cas9 KO screen identifying CTC-promoting genetic factors. (A) Experimental design of the genome-wide CRISPR-Cas9 KO screen

Updated on: December 25,2023

Gene loss enhances metastasis and cancer progression

by Melissa Rohman,Northwestern UniversityAn in vivo genome-wide CRISPR-Cas9 KO screen identifying CTC-promoting genetic factors. (A) Experimental design of the genome-wide CRISPR-Cas9 KO screen

Updated on:December 25,2023

Study shows clinical benefit of a new way of treating advanced ER+ breast cancer

by University of LiverpoolCredit: Unsplash/CC0 Public DomainA research paper published today inThe Lancet Oncologydemonstrates that the drug enobosarm, a selective androgen receptor m

Updated on: May 26,2024

Study shows clinical benefit of a new way of treating advanced ER+ breast cancer

by University of LiverpoolCredit: Unsplash/CC0 Public DomainA research paper published today inThe Lancet Oncologydemonstrates that the drug enobosarm, a selective androgen receptor m

Updated on:May 26,2024

Addition of durvalumab, bevacizumab to TACE beneficial in liver cancer

by Elana GotkineFor patients with embolization-eligible unresectable hepatocellular carcinoma (uHCC), the addition of durvalumab (D) and bevacizumab (B) to transarterial chemoembolization (TACE) impro

Updated on: March 22,2024

Addition of durvalumab, bevacizumab to TACE beneficial in liver cancer

by Elana GotkineFor patients with embolization-eligible unresectable hepatocellular carcinoma (uHCC), the addition of durvalumab (D) and bevacizumab (B) to transarterial chemoembolization (TACE) impro

Updated on:March 22,2024

Scientists discover metabolic feature that allows melanoma cells to spread

by Katie Regan,UT Southwestern Medical CenterResearchers involved in the study include (from left) Drs. Brandon Faubert, Alpaslan Tasdogan, Sean Morrison, and Ralph DeBerardinis. Credit: UTSWRes

Updated on: December 23,2023

Scientists discover metabolic feature that allows melanoma cells to spread

by Katie Regan,UT Southwestern Medical CenterResearchers involved in the study include (from left) Drs. Brandon Faubert, Alpaslan Tasdogan, Sean Morrison, and Ralph DeBerardinis. Credit: UTSWRes

Updated on:December 23,2023

Study shows which patients with advanced prostate cancer will benefit from chemotherapy

by University College LondonProstate cancer cells. Credit: NIH Image GalleryResearchers have recommended changes to how cancer patients are treated, after a new UCL-led study discovered that chem

Updated on: April 03,2024

Study shows which patients with advanced prostate cancer will benefit from chemotherapy

by University College LondonProstate cancer cells. Credit: NIH Image GalleryResearchers have recommended changes to how cancer patients are treated, after a new UCL-led study discovered that chem

Updated on:April 03,2024

Study hints at why an aggressive form of brain cancer is hard to treat

by Abbey Bigler,Broad Institute of MIT and HarvardAn illustration representing the cellular states of glioblastoma. Credit: Sébastien PerroudGlioblastoma is an incurable brain cancer that kills

Updated on: June 01,2024

Study hints at why an aggressive form of brain cancer is hard to treat

by Abbey Bigler,Broad Institute of MIT and HarvardAn illustration representing the cellular states of glioblastoma. Credit: Sébastien PerroudGlioblastoma is an incurable brain cancer that kills

Updated on:June 01,2024

FDA approves Vyloy for advanced gastric or gastroesophageal junction cancer

by Lori SolomonThe U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of a

Updated on: November 07,2024

FDA approves Vyloy for advanced gastric or gastroesophageal junction cancer

by Lori SolomonThe U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of a

Updated on:November 07,2024